tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market
Advertisement

Taiko Pharmaceutical Co., Ltd. (4574) Income Statement

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2024), Taiko Pharmaceutical Co., Ltd.'s total revenue was ¥1.71B, an increase of 0.59% from the same quarter last year. In Q4, Taiko Pharmaceutical Co., Ltd.'s net income was ¥184.00M. See Taiko Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 6.29B¥ 6.12B¥ 5.04B¥ 10.72B¥ 17.68B
Gross Profit
¥ 3.67B¥ 2.58B¥ 1.08B¥ 2.75B¥ 12.42B
Operating Expenses
¥ 3.04B¥ 3.58B¥ 4.16B¥ 7.69B¥ 6.77B
Depreciation and Amortization
¥ 256.00M¥ 704.00M¥ -671.00M¥ -620.00M¥ 272.52M
EBITDA
¥ 882.00M¥ -2.85B¥ -3.75B¥ -5.57B¥ 5.92B
Operating Income
¥ 629.00M¥ -1.00B¥ -3.08B¥ -4.95B¥ 5.65B
Other Income/Expenses
¥ -64.00M¥ -2.56B¥ -1.79B¥ -3.94B¥ -276.72M
Pretax Income
¥ 565.00M¥ -3.56B¥ -4.87B¥ -8.89B¥ 5.37B
Net Income
¥ 898.00M¥ -3.61B¥ -4.89B¥ -9.59B¥ 3.85B
Per Share Metrics
Basic EPS
¥ 17.89¥ -76.25¥ -112.24¥ -220.48¥ 89.18
Diluted EPS
¥ 17.89¥ -76.25¥ -112.24¥ -220.48¥ 88.82
Weighted Average Shares Outstanding
50.18M 47.36M 43.60M 43.51M 43.19M
Weighted Average Shares Outstanding (Diluted)
50.18M 47.36M 43.60M 43.51M 43.36M
Currency in JPY

Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis